{"name":"Biofrontera Bioscience GmbH","slug":"biofrontera-bioscience-gmbh","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"BF-200 ALA 1%","genericName":"BF-200 ALA 1%","slug":"bf-200-ala-1","indication":"Actinic keratosis","status":"phase_2"},{"name":"BF-200 ALA 10%","genericName":"BF-200 ALA 10%","slug":"bf-200-ala-10","indication":"Actinic keratosis (field treatment)","status":"phase_2"},{"name":"Placebo to BF-200 ALA gel","genericName":"Placebo to BF-200 ALA gel","slug":"placebo-to-bf-200-ala-gel","indication":"Actinic keratosis (field treatment)","status":"phase_3"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"BF-200 ALA 3%","genericName":"BF-200 ALA 3%","slug":"bf-200-ala-3","indication":"Actinic keratosis","status":"phase_2"}]}],"pipeline":[{"name":"BF-200 ALA 1%","genericName":"BF-200 ALA 1%","slug":"bf-200-ala-1","phase":"phase_2","mechanism":"BF-200 ALA 1% is a topical photosensitizer that, when activated by light, generates reactive oxygen species to induce cell death in targeted tissues.","indications":["Actinic keratosis","Superficial basal cell carcinoma"],"catalyst":""},{"name":"BF-200 ALA 10%","genericName":"BF-200 ALA 10%","slug":"bf-200-ala-10","phase":"phase_2","mechanism":"BF-200 ALA is a topical 5-aminolevulinic acid (ALA) formulation that generates reactive oxygen species upon light activation to destroy abnormal skin cells.","indications":["Actinic keratosis (field treatment)","Non-melanoma skin cancer precursor lesions"],"catalyst":""},{"name":"BF-200 ALA 3%","genericName":"BF-200 ALA 3%","slug":"bf-200-ala-3","phase":"phase_2","mechanism":"BF-200 ALA 3% is a topical cream used to treat actinic keratosis.","indications":["Actinic keratosis"],"catalyst":""},{"name":"Placebo to BF-200 ALA gel","genericName":"Placebo to BF-200 ALA gel","slug":"placebo-to-bf-200-ala-gel","phase":"phase_3","mechanism":"BF-200 ALA (aminolevulinic acid) gel is a photodynamic therapy agent that generates reactive oxygen species upon light activation to destroy abnormal skin cells.","indications":["Actinic keratosis (field treatment)","Non-melanoma skin cancer (basal cell carcinoma, squamous cell carcinoma)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxOSHdIUE9qUWQ3RGJLemxrRk51QkpGWlloUkNraHg4aTdtQVhUUC1VeTlHTHNFaC1rZkstN2pmd2YxTUlRdTZxb2RRT1JBY0FJY2pnenQ1dWhBZ2pWb3Q5ZUwyUXFzWjRkQWZlSVR1c2VrWTJvOGVUZjlVa1owZlRfeklRX1B2czRiNTJ2SjVqTU9JQ1VtTGFZQWpzNnV3TjZmeldqYkpfYkRxTHRnRDNB?oc=5","date":"2025-08-26","type":"pipeline","source":"Medscape","summary":"Red Light PDT With ALA Gel Shows High Clearance Rates for Superficial Basal Cell Carcinoma - Medscape","headline":"Red Light PDT With ALA Gel Shows High Clearance Rates for Superficial Basal Cell Carcinoma","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2021-12-01","type":"pipeline","source":"medicaldialogues.in","summary":"Sun Pharma arm DUSA Pharma to get Rs 170 crore in settlement with Biofrontera - medicaldialogues.in","headline":"Sun Pharma arm DUSA Pharma to get Rs 170 crore in settlement with Biofrontera","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6gFBVV95cUxPT1dRMmxXZEhhMFViSmwwYmNIaUI3QVVpMUJCNXVWOUNOUk9IUGo0LS1EQVVFMTRnb3pXTlo3ZGpHQXIxaDY3VWYxYnZlN1FpREhIZk45bUU3VExXVm4wVmR5TTVna0NNYWF1dmRpM2Exd1FKeV9QMWdERGFkY25EejJiZnJ1ZmpDUDVfQktpSGVBUnVoT0JZNzM1N29nMnFoekpZblhVdy1pN0htM1BoYWlRTmlQRTRiMFFaS214WUtkZFFsaVQydjQwM0F2OGtKLWJMdGxGMDh2REpzZzJEN0lkYWhnWmhBQnc?oc=5","date":"2021-10-28","type":"patent","source":"IPWatchdog.com","summary":"Patent Filings Roundup: Intellectual Ventures Jumps Stalled Car Campaign; DJ against Mystery Sons of Innovation LLC; Another Hundred Suits Dismissed - IPWatchdog.com","headline":"Patent Filings Roundup: Intellectual Ventures Jumps Stalled Car Campaign; DJ against Mystery Sons of Innovation LLC; Ano","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2018-12-27","type":"patent","source":"ET HealthWorld","summary":"Sun Pharma arm gets relief from US court in patent infringement case - ET HealthWorld","headline":"Sun Pharma arm gets relief from US court in patent infringement case","sentiment":"neutral"}],"patents":[],"drugCount":4,"phaseCounts":{"phase_2":3,"phase_3":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}